Cancer Genetics Inc. is an emerging leader in DNA-based cancer diagnostic testing. The company's proprietary tests target cancers that are difficult to diagnose and predict treatment outcomes that include hematologic, urogenital and HPV-associated cancers. Servicing prestigious medical institutions throughout the world, Cancer Genetics also offers a comprehensive range of non-proprietary, oncology-focused tests and laboratory services that provide critical genomic information to help devise patient management.
The information provided below is from analysts, newsletters and other contributors. Please contact the company and visit its website before making an investment decision.
Due to permission requirements, not all quotes are shown.
Cancer Genetics Inc. Content
CGIX' Video Interviews
Back to Top